人工智能在缺血性心脏病预防中的作用
Shyon Parsa1, Priyansh Shah2, Ritu Doijad3
1Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Current cardiology reports
|February 1, 2025
概括
人工智能 (AI) 通过先进的风险预测和个性化护理,增强了缺血性心脏病 (IHD) 的预防. 解决伦理问题和确保公平获取对于将AI整合到心脏病工作流程中至关重要.
科学领域:
- 心脏病学 心脏病学
- 人工智能的人工智能
- 预防医学 预防医学
背景情况:
- 缺血性心脏病 (IHD) 仍然是全球死亡的主要原因.
- 传统的风险评估方法在准确性和个性化方面存在局限性.
- 人工智能 (AI) 的整合在预防性心脏病学中带来了范式的转变.
研究的目的:
- 审查人工智能在预防缺血性心脏病 (IHD) 中的变革潜力.
- 探索AI在预测建模,生物标志物发现和心血管成像中取得的进展,以预防IHD.
- 讨论AI在预防性心脏病学中的临床整合方面的考虑.
主要方法:
- 关于人工智能在预防心血管疾病中的应用现有文献的综述.
- 分析人工智能驱动的工具,包括机器学习 (ML) 模型,用于风险预测.
- 检查AI在生物标志物发现和心血管成像分析中的作用.
主要成果:
- 人工智能通过整合多式联运数据显著改善了IHD风险预测,在准确度上超越了传统方法.
- 人工智能应用在生物标志物发现和增强心血管成像解释方面表现有前途.
- 挑战包括确保算法的公平性,减轻偏见,并提高道德部署的解释性.
结论:
- 人工智能在重塑预防性心脏病学方面具有重大前景,使得更精确的风险评估和个性化的患者护理成为可能.
- 像联合学习和可解释AI这样的新兴技术正在为公平和强大的AI采用铺平道路.
- 克服与公平,透明度和利益相关者参与相关的障碍对于成功的临床整合和改善心血管结果至关重要.
相关概念视频
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375